Although these products might confer significant advantages over the currently available treatments, there is still a huge unmet need for drugs that prevent the progression of COPD. Companies are ...

Chronic obstructive pulmonary disease is a serious, progressive illness that hits the homeless and underinsured the hardest.

"One of the key takeaways was the necessity of personalisation, not just in medications but also ... approaches and shared best practices. Patients with COPD often experience chronic cough ...

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials ...

Tudorza and Duaklir are inhaled respiratory drugs for chronic obstructive pulmonary disease (COPD) – and at the time of the deal Tudorza (aclidinium bromide), a long-acting muscarinic agonist ...

When will we know who won the 2024 presidential election? Experts weigh in Gargantuan Blob In Utah Is Up To 80,000 Years Old And Among Earth's Oldest Organisms Terry Bradshaw's new career switch ...

reckons a chronic obstructive pulmonary disease (COPD) drug will be included – and is preparing to contribute to the process. ICER isn't officially involved in the price negotiations introduced ...